Retension Pharmaceuticals, Inc. ($RTSN)
Filing Information
| Accession Number | 0001213900-26-109160 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 13, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
358,034
Total Value
$249,600.00
P&L
+29.2% (+$72,800.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Oct 13, 2026 | Purchase | 20,800 | $12.00 | $249,600.00 | 423,377 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 13, 2026 | Conversion | 9,662 | โ | โ | 433,039 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 13, 2026 | Conversion | 31,368 | โ | โ | 464,407 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Oct 13, 2026 | Grant/Award | 255,174 | $0.00 | $0.00 | 255,174 | Direct | โ | View Details | |
Director | Series A Convertible Preferred Stock | Derivative | Oct 13, 2026 | Conversion | 9,662 | โ | โ | 0 | Direct | โ | View Details | |
Director | Series B Convertible Preferred Stock | Derivative | Oct 13, 2026 | Conversion | 31,368 | โ | โ | 0 | Direct | โ | View Details |